UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Nature communications, 2023-08, Vol.14 (1), p.5219-5219, Article 5219

2023

Volltextzugriff (PDF)

Comprehensive review of telbivudine in pregnant women with chronic hepatitis B

World journal of hepatology, 2016-03, Vol.8 (9), p.452-460

2016

Volltextzugriff (PDF)

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B

PloS one, 2013-02, Vol.8 (2), p.e54279-e54279

2013

Volltextzugriff (PDF)

Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events

Journal of hepatology, 2022-05, Vol.76 (5), p.1013-1020

2022

Volltextzugriff (PDF)

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Gut, 2022-05, Vol.71 (5), p.1006-1019

2022

Volltextzugriff (PDF)

Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study

Journal of hepatology, 2022-03, Vol.76 (3), p.536-548

2022

Volltextzugriff (PDF)

WED-296 PLIN2 is a specific marker for liver related disease

Journal of hepatology, 2024-06, Vol.80, p.S545-S546

2024

Volltextzugriff (PDF)

Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes

Liver international, 2022-05, Vol.42 (5), p.984-994

2022

Volltextzugriff (PDF)

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Journal of hepatology, 2021-10, Vol.75 (4), p.770-785

2021

Volltextzugriff (PDF)

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

Drugs in Context, 2016-04, Vol.5, p.212294-9

2016

Volltextzugriff (PDF)

WED-215 HeparDx™ (by Metadeq, Inc.) is a reliable biomarker-based non-invasive test for MASH, capable of detecting the presence of inflammation and ballooning

Journal of hepatology, 2024-06, Vol.80, p.S516-S516

2024

Volltextzugriff (PDF)

Comparative Selection of the K65R and M184V/I Mutations in Human Immunodeficiency Virus Type 1-Infected Patients Enrolled in a Trial of First-Line Triple-Nucleoside Analog Therapy (Tonus IMEA 021)

Journal of Virology, 2005-08, Vol.79 (15), p.9572-9578

2005

Volltextzugriff (PDF)

The burden of disease associated with non-alcoholic steatohepatitis patients under standard of care

Journal of hepatology, 2020-08, Vol.73, p.S164

2020

Volltextzugriff (PDF)

THU048 - The burden of disease associated with non-alcoholic steatohepatitis patients under standard of care

Journal of hepatology, 2020-08, Vol.73, p.S164-S164

2020

Volltextzugriff (PDF)

SAT-427 - Practical diagnosis of cirrhosis by liver specialists in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Journal of hepatology, 2023-06, Vol.78, p.S672-S673

2023

Volltextzugriff (PDF)

Practical diagnosis of cirrhosis by liver specialists in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Journal of hepatology, 2023-06, Vol.78, p.S672-S673

2023

Volltextzugriff (PDF)

Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B

Gastroenterology (New York, N.Y. 1943), 2014, Vol.146 (1), p.138-146.e5

2014

Volltextzugriff (PDF)

Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study

Journal of hepatology, 2020-08, Vol.73, p.S489

2020

Volltextzugriff (PDF)

FRI180 - Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study

Journal of hepatology, 2020-08, Vol.73, p.S489-S489

2020

Volltextzugriff (PDF)

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

The lancet. Gastroenterology & hepatology, 2023-08, Vol.8 (8), p.704-713

2023

Volltextzugriff (PDF)

Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients

Antiviral therapy, 2004-06, Vol.9 (3), p.315-323

2004

Volltextzugriff (PDF)

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study

Hepatology (Baltimore, Md.), 2023-07, Vol.78 (1), p.258-271

2023

Volltextzugriff (PDF)

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy

Journal of hepatology, 2015-01, Vol.62 (1), p.41-47

2015

Volltextzugriff (PDF)

Proposition d’un parcours de soin pour les patients à risque de stéatohépatite non-alcoolique avec fibrose avancée : consensus DELPHI

Médecine des maladies métaboliques, 2023-05, Vol.17 (3), p.271-280

2023

Volltextzugriff (PDF)

1 – 25 von 43

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(41)
Mit Volltextzugriff
(39)

Publikationsform

Artikel
(43)

Sprache

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

Journal Of Hepatology
(12)
Liver International
(3)
Hepatology
(2)
Hepatology International
(2)
Journal Of Acquired Immune Deficiency Syndromes
(2)
Plos One
(2)
Advances In Therapy
(1)
Aids
(1)
Antiviral Therapy
(1)
Drugs In Context
(1)

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Practical diagnosis of cirrhosis in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Comprehensive review of telbivudine in pregnant women with chronic hepatitis B

52-week efficacy and safety of telbivudine with conditional tenofovir intensification at week 24 in HBeAg-positive chronic hepatitis B

Non-invasive tests accurately stratify patients with NAFLD based on their risk of liver-related events

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis

Non-invasive evaluation of response to obeticholic acid in patients with NASH: Results from the REGENERATE study

WED-296 PLIN2 is a specific marker for liver related disease

Knowledge of liver fibrosis stage among adults with NAFLD/NASH improves adherence to lifestyle changes

Diagnostic accuracy of elastography and magnetic resonance imaging in patients with NAFLD: A systematic review and meta-analysis

Efficacy of telbivudine with conditional tenofovir intensification in patients with chronic hepatitis B: results from the 2-year roadmap strategy

WED-215 HeparDx™ (by Metadeq, Inc.) is a reliable biomarker-based non-invasive test for MASH, capable of detecting the presence of inflammation and ballooning

Comparative Selection of the K65R and M184V/I Mutations in Human Immunodeficiency Virus Type 1-Infected Patients Enrolled in a Trial of First-Line Triple-Nucleoside Analog Therapy (Tonus IMEA 021)

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis

The burden of disease associated with non-alcoholic steatohepatitis patients under standard of care

THU048 - The burden of disease associated with non-alcoholic steatohepatitis patients under standard of care

SAT-427 - Practical diagnosis of cirrhosis by liver specialists in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Practical diagnosis of cirrhosis by liver specialists in non-alcoholic fatty liver disease using currently available non-invasive fibrosis tests

Telbivudine Improves Renal Function in Patients With Chronic Hepatitis B

Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study

FRI180 - Efficacy and tolerance of obeticholic acid in patients with primary biliary cholangitis and inadequate response to ursodeoxycholic acid in real life: interim analysis of the OCARELIFE study

Performance of non-invasive tests and histology for the prediction of clinical outcomes in patients with non-alcoholic fatty liver disease: an individual participant data meta-analysis

Genotypic determinants of the virological response to tenofovir disoproxil fumarate in nucleoside reverse transcriptase inhibitor-experienced patients

Machine learning algorithm improves the detection of NASH (NAS-based) and at-risk NASH: A development and validation study

Telbivudine plus pegylated interferon alfa-2a in a randomized study in chronic hepatitis B is associated with an unexpected high rate of peripheral neuropathy

Proposition d’un parcours de soin pour les patients à risque de stéatohépatite non-alcoolique avec fibrose avancée : consensus DELPHI

Suchergebnisse filtern